Welcome to our dedicated page for SharonAI SEC filings (Ticker: SHAZD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SharonAI's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SharonAI's regulatory disclosures and financial reporting.
SharonAI Holdings Inc. director Cairns Alastair John filed an initial statement of ownership, listing equity awards rather than new trades. He reports direct ownership of stock options covering 18,643 shares and restricted stock units covering 39,904 shares.
The footnote explains that each restricted stock unit represents a contingent right to receive one share of SHAZ Class A Ordinary Common Stock. One-third of these units will vest on each of the first, second and third anniversaries of the grant date, and the units have no expiration date.
SharonAI Holdings Inc. filed an initial ownership report for its Chief Financial Officer, Timothy George Broadfoot. The Form 3 shows he holds various restricted stock units (RSUs) that each represent a contingent right to receive one share of SHAZ Class A Ordinary Common Stock.
Some RSUs are fully vested with no expiration date, while others vest only if the company meets specific performance or event milestones. These include a valuation above
SharonAI Holdings Inc. is registering 2,500,000 shares of Class A Ordinary Common Stock in a primary offering expected to raise approximately $125,000,000 at an assumed price of $50.00 per share. All shares are sold by the company, which will receive the net proceeds.
The filing supports an uplisting from the OTC Pink Open Market to the Nasdaq Capital Market under the symbol “SHAZ,” alongside existing OTC trading of common stock and public warrants. The company has granted underwriters a 45‑day option to purchase up to 375,000 additional shares to cover over‑allotments and will also issue underwriter warrants equal to 4% of shares sold.
Net proceeds are estimated at about $116,250,000 (or $133,687,500 if the over‑allotment is fully exercised) and are earmarked mainly to acquire additional GPU‑focused equipment and for working capital and general corporate purposes. Shares outstanding will increase from 11,968,505 to 14,468,505 after the offering, excluding options, warrants, equity plan reserves and up to 8,251,027 shares issuable upon conversion of AU Convertible Notes.
SharonAI Holdings Inc. reported the resignation of director Brent Lanier from its Board of Directors, effective January 29, 2026. The company states that his departure is not due to any dispute or disagreement with management or the company’s operations, policies, or practices.
SharonAI Holdings, Inc. has filed a Form S-1 to register the resale of 5,270,586 existing Class A Ordinary shares and up to 214,982 additional shares issuable upon exercise of private warrants, plus a primary registration for up to 230,000 shares underlying public warrants. These shares stem mainly from its December 17, 2025 business combination with Roth CH Acquisition Co. and the conversion of $2.25 million of 10% convertible notes at $6.00 per share. The company will not receive proceeds from resales by selling shareholders, but could receive up to approximately $256 million in gross proceeds if all 444,982 warrants are exercised for cash at an exercise price of $575.00 per share. As of January 16, 2026, 11,967,005 common shares were outstanding, and the stock and public warrants trade on the OTC Markets under the symbols SHAZ and SHAZW. The prospectus also details a 1-for-50 reverse stock split, the high-risk nature of the business, and substantial new financing and asset transactions.